These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27212420)

  • 1. Effect of Serotonin 1A Agonists and Selective Serotonin Reuptake Inhibitors on Behavioral and Nighttime Respiratory Symptoms in Rett Syndrome.
    Ohno K; Saito Y; Ueda R; Togawa M; Ohmae T; Matsuda E; Fujiyama M; Maegaki Y
    Pediatr Neurol; 2016 Jul; 60():54-59.e1. PubMed ID: 27212420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polysomnographic characteristics of patients with Rett syndrome.
    Marcus CL; Carroll JL; McColley SA; Loughlin GM; Curtis S; Pyzik P; Naidu S
    J Pediatr; 1994 Aug; 125(2):218-24. PubMed ID: 8040765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnea.
    Kraiczi H; Hedner J; Dahlöf P; Ejnell H; Carlson J
    Sleep; 1999 Feb; 22(1):61-7. PubMed ID: 9989366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of buspirone and fluoxetine for breathing problems in Rett syndrome.
    Gökben S; Ardıç UA; Serdaroğlu G
    Pediatr Neurol; 2012 Mar; 46(3):192-4. PubMed ID: 22353299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A selective 5-HT1a receptor agonist improves respiration in a mouse model of Rett syndrome.
    Levitt ES; Hunnicutt BJ; Knopp SJ; Williams JT; Bissonnette JM
    J Appl Physiol (1985); 2013 Dec; 115(11):1626-33. PubMed ID: 24092697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep-Disordered Breathing in Pediatric Patients With Rett Syndrome.
    Sarber KM; Howard JJM; Dye TJ; Pascoe JE; Simakajornboon N
    J Clin Sleep Med; 2019 Oct; 15(10):1451-1457. PubMed ID: 31596210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of respiratory disorders in a mouse model of Rett syndrome.
    Abdala AP; Dutschmann M; Bissonnette JM; Paton JF
    Proc Natl Acad Sci U S A; 2010 Oct; 107(42):18208-13. PubMed ID: 20921395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective serotonin reuptake inhibitor use is associated with worse sleep-related breathing disturbances in individuals with depressive disorders and sleep complaints: a retrospective study.
    Robillard R; Saad M; Ray LB; BuJáki B; Douglass A; Lee EK; Soucy L; Spitale N; De Koninck J; Kendzerska T
    J Clin Sleep Med; 2021 Mar; 17(3):505-513. PubMed ID: 33118928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of progesterone on apneic events during behaviorally defined sleep in male rats.
    Yamazaki H; Haji A; Ohi Y; Takeda R
    Life Sci; 2005 Dec; 78(4):383-8. PubMed ID: 16107262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT(1A)-receptor over-expressing mice: genotype and sex dependent responses to antidepressants in the forced swim-test.
    Günther L; Rothe J; Rex A; Voigt JP; Millan MJ; Fink H; Bert B
    Neuropharmacology; 2011 Sep; 61(3):433-41. PubMed ID: 21419787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic potential.
    Veasey SC
    Am J Respir Med; 2003; 2(1):21-9. PubMed ID: 14720019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory and sleep disorders in female children with atypical Rett syndrome caused by mutations in the CDKL5 gene.
    Hagebeuk EE; van den Bossche RA; de Weerd AW
    Dev Med Child Neurol; 2013 May; 55(5):480-4. PubMed ID: 23151060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 5-hydroxytryptamine and 5-hydroxytryptamine 2A/2C agonist on the genioglossus activity and sleep apnea in rats.
    Zhong YJ; Zhang C; Wang GF
    Chin Med J (Engl); 2010 Aug; 123(15):2094-8. PubMed ID: 20819548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ondansetron and fluoxetine reduce sleep apnea in mice lacking monoamine oxidase A.
    Real C; Seif I; Adrien J; Escourrou P
    Respir Physiol Neurobiol; 2009 Sep; 168(3):230-8. PubMed ID: 19615472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathophysiology of the Rett syndrome from the standpoint of polysomnography.
    Segawa M; Nomura Y
    Brain Dev; 1990; 12(1):55-60. PubMed ID: 2344028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Sarizotan, a 5-HT1a and D2-like receptor agonist, on respiration in three mouse models of Rett syndrome.
    Abdala AP; Lioy DT; Garg SK; Knopp SJ; Paton JF; Bissonnette JM
    Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1031-9. PubMed ID: 24351104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional role for cannabinoids in respiratory stability during sleep.
    Carley DW; Paviovic S; Janelidze M; Radulovacki M
    Sleep; 2002 Jun; 25(4):391-8. PubMed ID: 12071539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep in postpolio syndrome.
    Steljes DG; Kryger MH; Kirk BW; Millar TW
    Chest; 1990 Jul; 98(1):133-40. PubMed ID: 2361379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and Consequences of Non-apneic Respiratory Events During Sleep.
    Sankari A; Pranathiageswaran S; Maresh S; Hosni AM; Badr MS
    Sleep; 2017 Jan; 40(1):. PubMed ID: 28364453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.